Market Tracker

11/27 6:05pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.716
Data as of Nov 26
 +0.016 / +2.29%
Today’s Change
0.69
Today|||52-Week Range
1.48
-41.79%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close0.70
Today’s open0.70
Day’s range0.70 - 0.72
Volume28,225
Average volume (3 months)172,291
Market cap$37.0M
Dividend yield--
Data as of 3:49pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-75.00%
Earnings growth (this year)+28.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-49.95%
P/E ratioNM
Price/Sales13.51
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
BIODBiodel Inc-0.03-1.92%
--Altovida Inc0.000.00%
GNVCGenVec Inc-0.02-1.17%
OGENOragenics Inc+0.10+10.59%
Data as of 3:59pm ET, 11/26/2014

Financials

Last reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$3.5M
Annual profit (last year)-$16.0M
Net profit margin-461.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts